R. Michael Baldwin

1.1k total citations
19 papers, 849 citations indexed

About

R. Michael Baldwin is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, R. Michael Baldwin has authored 19 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in R. Michael Baldwin's work include Pharmacogenetics and Drug Metabolism (9 papers), Chemical Reactions and Isotopes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). R. Michael Baldwin is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Chemical Reactions and Isotopes (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). R. Michael Baldwin collaborates with scholars based in United States, Sweden and Japan. R. Michael Baldwin's co-authors include Alan R. Buckpitt, Magnus Ingelman‐Sundberg, Jessica Mwinyi, Erik Eliasson, Leif Bertilsson, Rasmus S. Pedersen, Michael A. Shultz, Charles G. Plopper, Deanna L. Kroetz and Michelle V. Fanucchi and has published in prestigious journals such as Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics and International Journal of Obesity.

In The Last Decade

R. Michael Baldwin

18 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Michael Baldwin United States 16 323 294 213 126 80 19 849
Lucia F. Jorge-Nebert United States 9 137 0.4× 276 0.9× 186 0.9× 56 0.4× 40 0.5× 11 583
Amanda Obaidat United States 5 645 2.0× 171 0.6× 263 1.2× 49 0.4× 26 0.3× 5 1.0k
Michael S. Rose United Kingdom 18 140 0.4× 212 0.7× 535 2.5× 82 0.7× 75 0.9× 44 1.3k
Nadine Dragin France 22 216 0.7× 280 1.0× 394 1.8× 263 2.1× 30 0.4× 32 1.6k
Zeen Tong United States 15 139 0.4× 207 0.7× 397 1.9× 84 0.7× 53 0.7× 35 846
Ajay Madan United States 13 401 1.2× 598 2.0× 245 1.2× 69 0.5× 21 0.3× 15 1.1k
Yoshikazu Emi Japan 16 286 0.9× 423 1.4× 400 1.9× 94 0.7× 10 0.1× 34 983
Rushang D. Patel United States 12 94 0.3× 82 0.3× 282 1.3× 108 0.9× 93 1.2× 37 763
Y. Barra France 13 219 0.7× 189 0.6× 257 1.2× 88 0.7× 10 0.1× 28 652
Michele Campaigne Larsen United States 16 105 0.3× 196 0.7× 283 1.3× 205 1.6× 17 0.2× 30 697

Countries citing papers authored by R. Michael Baldwin

Since Specialization
Citations

This map shows the geographic impact of R. Michael Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Baldwin more than expected).

Fields of papers citing papers by R. Michael Baldwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Michael Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Baldwin. The network helps show where R. Michael Baldwin may publish in the future.

Co-authorship network of co-authors of R. Michael Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of R. Michael Baldwin. A scholar is included among the top collaborators of R. Michael Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Michael Baldwin. R. Michael Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kanodia, Jitendra, Arthur Lo, R. Michael Baldwin, Richard Graham, & David L. Bourdet. (2020). Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain. Clinical Pharmacokinetics. 60(1). 121–131. 4 indexed citations
2.
Kanodia, Jitendra, et al.. (2020). Safety, Pharmacokinetics, and Pharmacodynamics of TD‐0714, a Novel Potent Neprilysin Inhibitor in Healthy Adult and Elderly Subjects. Clinical and Translational Science. 13(6). 1307–1315.
3.
Baldwin, R. Michael, et al.. (2015). Arginine methyltransferases as novel therapeutic targets for breast cancer. Mutagenesis. 30(2). 177–189. 41 indexed citations
4.
Chhibber, Aparna, Joel Mefford, Eli A. Stahl, et al.. (2014). Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). The Pharmacogenomics Journal. 14(4). 336–342. 26 indexed citations
5.
Baldwin, R. Michael, Kouros Owzar, Hitoshi Zembutsu, et al.. (2012). A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101. Clinical Cancer Research. 18(18). 5099–5109. 160 indexed citations
6.
Wheeler, Heather E., Eric R. Gamazon, Claudia Wing, et al.. (2012). Integration of Cell Line and Clinical Trial Genome-Wide Analyses Supports a Polygenic Architecture of Paclitaxel-Induced Sensory Peripheral Neuropathy. Clinical Cancer Research. 19(2). 491–499. 49 indexed citations
7.
Nguyen, Thai, Svetlana Markova, Wanqing Liu, et al.. (2012). Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression. The Pharmacogenomics Journal. 13(5). 396–402. 31 indexed citations
8.
Wu, Jerry, R. Michael Baldwin, Magnus Ingelman‐Sundberg, et al.. (2011). Omeprazole limited sampling strategies to predict area under the concentration–time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping. European Journal of Clinical Pharmacology. 68(4). 407–413. 4 indexed citations
9.
Lin, Ching‐Yu, Åsa M. Wheelock, Dexter Morin, et al.. (2009). Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene. Toxicology. 260(1-3). 16–27. 38 indexed citations
10.
Baldwin, R. Michael, Ylva Terelius, Ronny Fransson-Steen, et al.. (2009). Regulation of Human CYP2C18 and CYP2C19 in Transgenic Mice: Influence of Castration, Testosterone, and Growth Hormone. Drug Metabolism and Disposition. 37(7). 1505–1512. 20 indexed citations
11.
Rosenborg, Staffan, Jessica Mwinyi, Maria Andersson, et al.. (2008). Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects. European Journal of Clinical Pharmacology. 64(12). 1175–1179. 53 indexed citations
12.
Baldwin, R. Michael, Rasmus S. Pedersen, Jessica Mwinyi, et al.. (2008). Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers. British Journal of Clinical Pharmacology. 65(5). 767–774. 119 indexed citations
13.
Baldwin, R. Michael, Masahiro Hiratsuka, Sarah C. Sim, et al.. (2008). Generation of Mice Transgenic for Human CYP2C18 and CYP2C19: Characterization of the Sexually Dimorphic Gene and Enzyme Expression. Drug Metabolism and Disposition. 36(5). 955–962. 39 indexed citations
14.
Baldwin, R. Michael, Michael A. Shultz, & Alan R. Buckpitt. (2005). Bioactivation of the Pulmonary Toxicants Naphthalene and 1-Nitronaphthalene by Rat CYP2F4. Journal of Pharmacology and Experimental Therapeutics. 312(2). 857–865. 34 indexed citations
15.
Forkert, Poh‐Gek, R. Michael Baldwin, Brandie Millen, et al.. (2005). PULMONARY BIOACTIVATION OF TRICHLOROETHYLENE TO CHLORAL HYDRATE: RELATIVE CONTRIBUTIONS OF CYP2E1, CYP2F, AND CYP2B1. Drug Metabolism and Disposition. 33(10). 1429–1437. 19 indexed citations
16.
Baldwin, R. Michael, William T. Jewell, Michelle V. Fanucchi, Charles G. Plopper, & Alan R. Buckpitt. (2004). Comparison of Pulmonary/Nasal CYP2F Expression Levels in Rodents and Rhesus Macaque. Journal of Pharmacology and Experimental Therapeutics. 309(1). 127–136. 42 indexed citations
17.
Reilly, Christopher A., R. Michael Baldwin, Burhan I. Ghanayem, et al.. (2004). BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES. Drug Metabolism and Disposition. 32(9). 1032–1039. 27 indexed citations
18.
Buckpitt, Alan R., Didier Morin, Michael A. Shultz, et al.. (2002). NAPHTHALENE-INDUCED RESPIRATORY TRACT TOXICITY: METABOLIC MECHANISMS OF TOXICITY. Drug Metabolism Reviews. 34(4). 791–820. 108 indexed citations
19.
Åhrén, Bo, R. Michael Baldwin, & Peter J. Havel. (2000). Pharmacokinetics of human leptin in mice and rhesus monkeys. International Journal of Obesity. 24(12). 1579–1585. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia F. Jorge-Nebert Breakdown of academic impact, for papers by Amanda Obaidat Breakdown of academic impact, for papers by Michael S. Rose Breakdown of academic impact, for papers by Nadine Dragin Breakdown of academic impact, for papers by Zeen Tong Breakdown of academic impact, for papers by Ajay Madan Breakdown of academic impact, for papers by Yoshikazu Emi Breakdown of academic impact, for papers by Rushang D. Patel Breakdown of academic impact, for papers by Y. Barra Breakdown of academic impact, for papers by Michele Campaigne Larsen
Rankless by CCL
2026